Clincosm LogoSign in Get a demo

bronchial neoplasms

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +14 more
  • Glendale, California
  • +12 more
Feb 2, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Bronchial Tumors Trial in Germany, Spain (EGF816, Trametinib)

Recruiting
  • Bronchial Neoplasms
  • Cologne, Germany
  • +6 more
Nov 2, 2022

Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

Recruiting
  • Lung Neoplasms
  • +23 more
  • La Jolla, California
  • +35 more
Oct 6, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)

Completed
  • Neoplasms
  • +14 more
  • San Antonio, Texas
    The START Center for Cancer Care
Apr 21, 2022

Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

Recruiting
  • Lung Neoplasm Malignant
  • +18 more
  • Fairfax, Virginia
    New Experimental Therapeutics of Virginia (NEXT Oncology)
Mar 29, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

Completed
  • Neoplasms
  • +13 more
  • San Antonio, Texas
    The START Center for Cancer Care
Jan 24, 2022

Bronchial Tumors Trial in Trondheim (navigated bronchoscopy)

Recruiting
  • Bronchial Neoplasms
  • navigated bronchoscopy
  • Trondheim, Norway
    Department of Thoracic Medicine, St Olavs Hospital
Dec 29, 2021

New Open Source Virtual Bronchoscope Navigation System

Suspended
  • Bronchial Neoplasms
  • Fraxinus VBN system
  • Trondheim, Norway
    St Olavs Hospital
Nov 29, 2021

Lung Tumors, Squamous Cell Lung Cancer, Adenocarcinoma of the Lung Trial in Guangzhou (Icotinib)

Recruiting
  • Lung Neoplasms
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 29, 2021

Stage IV, NSCLC, Lung Tumors, Bronchial Tumors Trial in Italy (Carboplatin, Gemcitabine, Pemetrexed)

Recruiting
  • Stage IV, NSCLC
  • +8 more
  • Meldola, Forlì, Italy
  • +27 more
Nov 3, 2020

Solitary Pulmonary Nodule, Bronchial Tumors Trial in St. Gallen (Radioactive labelling of pulmonary nodules, CT guided

Terminated
  • Solitary Pulmonary Nodule
  • Bronchial Neoplasms
  • Radioactive labelling of pulmonary nodules
  • +2 more
  • St. Gallen, Switzerland
    Cantonal Hospital St.Gallen
Feb 1, 2017

Circulating Tumor DNA in Late Stage NSCLC Patients

Unknown status
  • Carcinoma, Non-Small-Cell Lung
  • +4 more
    • Wenzhou, Zhejiang, China
      Wenzhou Medical University
    Oct 31, 2016

    Bronchial Tumors Trial in Trondheim (navigated bronchoscopy)

    Completed
    • Bronchial Neoplasms
    • navigated bronchoscopy
    • Trondheim, Norway
      Department of Thoracic Medicine, St Olavs Hospital
    Mar 29, 2016

    Fixation of Various Vectors in PET/CT inWith Lung Cancer Before

    Completed
    • Bronchial Neoplasms
    • Carcinoma, Non-Small-Cell Lung
      • Rouen, Hate Normandie, France
        Centre Henri Becquerel
      Dec 15, 2010